These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Therapeutic action of a monoamine oxidase inhibitor, marsilid (iproniazid), on depressive states]. DICK P. Schweiz Med Wochenschr; 1959 Dec 05; 89():1288-91. PubMed ID: 13816578 [No Abstract] [Full Text] [Related]
23. METHIONINE EFFECTS ON CHRONIC SCHIZOPHRENICS: PATIENTS TREATED WITH MONOAMINE OXIDASE INHIBITORS. PARK LC, BALDESSARINI RJ, KETY SS. Arch Gen Psychiatry; 1965 Apr 05; 12():346-51. PubMed ID: 14258360 [No Abstract] [Full Text] [Related]
25. [ANTIDEPRESSIVE TREATMENT WITH MONOAMINE OXIDASE (MAO) INHIBITORS. I. SIDE-EFFECTS AND RISKS OF POTENTIATION]. HOLMBERG G, SJOEQVIST F. Sven Lakartidn; 1964 Dec 02; 61():3762-93. PubMed ID: 14276462 [No Abstract] [Full Text] [Related]
26. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge]. Volz HP, Gleiter CH, Möller HJ. Nervenarzt; 1996 May 02; 67(5):339-47. PubMed ID: 9005342 [Abstract] [Full Text] [Related]
27. A clinical and biochemical study of monoamine oxidase inhibition in depressed patients. II. 5-Hydroxytryptamine tolerance before and after Nialamide. DEWHURST WG, PARE CM. J Ment Sci; 1961 Mar 02; 107():244-9. PubMed ID: 13722404 [No Abstract] [Full Text] [Related]
28. [ANTIDEPRESSIVE TREATMENT WITH MONOAMINE OXIDASE (MAO) INHIBITORS. II. DRUG-THERAPEUTIC INQUIRY ON CEREBROVASCULAR SIDE-EFFECTS, WITH MEDICOLEGAL ASPECTS OF THE USE OF MAO INHIBITORS]. HOLMBERG G, SJOEQVIST F. Sven Lakartidn; 1964 Dec 02; 61():3794-807. PubMed ID: 14276463 [No Abstract] [Full Text] [Related]
29. Variable action of monoamine oxidase-inhibiting hydrazines on serotonin metabolism. KIRBERGER E. Nature; 1963 Mar 23; 197():1211-2. PubMed ID: 14032954 [No Abstract] [Full Text] [Related]
30. Direct measurement of monoamine oxidase inhibition in humans. LEVINE RJ, SJOERDSMA A. Clin Pharmacol Ther; 1963 Mar 23; 4():22-7. PubMed ID: 13930166 [No Abstract] [Full Text] [Related]
31. Monoamine oxidase inhibitors revisited: what you should know. Goldberg JF, Thase ME. J Clin Psychiatry; 2013 Feb 23; 74(2):189-91. PubMed ID: 23473352 [No Abstract] [Full Text] [Related]
32. [Preliminary study of the therapeutic action of a new monoamine oxidase inhibitor. Ro 5-0831]. BURGERMEISTER JJ, DICK P, GARRONE G, TISSOT R. Praxis; 1960 Jan 21; 49():45-7. PubMed ID: 13806071 [No Abstract] [Full Text] [Related]
33. HYPERTENSION WITH MONOAMINE OXIDASE INHIBITORS. OGILVIE C. Br Med J; 1964 May 16; 1(5393):1313-4. PubMed ID: 14123646 [No Abstract] [Full Text] [Related]
34. [Apropos of iproniazid. Inhibition of monoamine oxidase in therapy]. HOLZER J, SOLIGNAC H. Prod Pharm; 1961 Oct 16; 16():482-4. PubMed ID: 13908637 [No Abstract] [Full Text] [Related]
35. Anxiety state or masked depression? A study based on the action of monoamine oxidase inhibitors. Pollitt J, Young J. Br J Psychiatry; 1971 Aug 16; 119(549):143-9. PubMed ID: 5565901 [No Abstract] [Full Text] [Related]
37. Analgesic effect of some monoamine oxidase inhibitors. Jauhari AC, Bapat SK. Indian J Physiol Pharmacol; 1971 Jan 16; 15(1):21-6. PubMed ID: 5122772 [No Abstract] [Full Text] [Related]
38. [The use of a new monoamine oxidase (marplan) in neurological practice]. MEUSERT W. Med Welt; 1960 Nov 26; 48():2559-61. PubMed ID: 13769938 [No Abstract] [Full Text] [Related]
39. ON THE MECHANISM OF EMESIS INDUCED BY 5-HYDROXYTRYPTAMINE. CAHEN RL. Proc Soc Exp Biol Med; 1964 Jun 26; 116():402-4. PubMed ID: 14189150 [No Abstract] [Full Text] [Related]
40. Reversible monoamine oxidase-A inhibitors in resistant major depression. Nolen WA, Hoencamp E, Bouvy PF, Haffmans PM. Clin Neuropharmacol; 1993 Jun 26; 16 Suppl 2():S69-76. PubMed ID: 8313400 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]